Alterity Therapeutics (ATH.AX) Trading Snapshot
- Last closing price: AUD 0.26
- 24‑hour performance: down 5.56 % as of 12:07 AM Central Europe, Friday 23 Oct 2026
- Volume (last 24 h): AUD 194.2 k
- Shares outstanding: 218.5 million
- Market capitalization: AUD 55.7 million
- 12‑month price range:
- Highest: AUD 0.78 on 07 Jul 2026
- Lowest: AUD 0.24 on 21 Oct 2026
- 200‑day simple moving average: AUD 0.46
- Month‑to‑month change: down 39.29 % since the end of the previous month
24‑hour performance of related stocks
| Ticker | 24‑hour change | Current price | Market cap (AUD m) |
|---|---|---|---|
| CRI.AX (Critica) | –4.35 % | 0.02 | 66.7 |
| OCN.AX (Oceana Metals) | +3.57 % | 0.30 | 65.9 |
| LAC.AX (Lac Gold) | +8.20 % | 0.29 | 65.6 |
| PTX.AX (Prescient Therapeutics) | –1.72 % | 0.06 | 66.3 |
| AVE.AX (Avecho Biotechnology) | +21.43 % | 0.02 | 65.7 |
Company overview
Alterity Therapeutics Limited is a biotechnology firm headquartered in Melbourne, Australia, listed on the ASX All Markets exchange. The company focuses on the research and development of therapeutic agents for Alzheimer’s disease and other age‑related disorders. Its primary market is Australia, where it provides patient care services. Further information can be accessed on its website: www.alteritytherapeutics.com .
